Skip to main content

Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities.

Publication ,  Journal Article
Berry, SD; Goldfeld, KS; McConeghy, K; Gifford, D; Davidson, HE; Han, L; Syme, M; Gandhi, A; Mitchell, SL; Harrison, J; Recker, A; Johnson, KS ...
Published in: JAMA Intern Med
March 1, 2022

IMPORTANCE: Identifying successful strategies to increase COVID-19 vaccination among skilled nursing facility (SNF) residents and staff is integral to preventing future outbreaks in a continually overwhelmed system. OBJECTIVE: To determine whether a multicomponent vaccine campaign would increase vaccine rates among SNF residents and staff. DESIGN, SETTING, AND PARTICIPANTS: This was a cluster randomized trial with a rapid timeline (December 2020-March 2021) coinciding with the Pharmacy Partnership Program (PPP). It included 133 SNFs in 4 health care systems across 16 states: 63 and 70 facilities in the intervention and control arms, respectively, and participants included 7496 long-stay residents (>100 days) and 17 963 staff. INTERVENTIONS: Multicomponent interventions were introduced at the facility level that included: (1) educational material and electronic messaging for staff; (2) town hall meetings with frontline staff (nurses, nurse aides, dietary, housekeeping); (3) messaging from community leaders; (4) gifts (eg, T-shirts) with socially concerned messaging; (5) use of a specialist to facilitate consent with residents' proxies; and (6) funds for additional COVID-19 testing of staff/residents. MAIN OUTCOMES AND MEASURES: The primary outcomes of this study were the proportion of residents (from electronic medical records) and staff (from facility logs) who received a COVID-19 vaccine (any), examined as 2 separate outcomes. Mixed-effects generalized linear models with a binomial distribution were used to compare outcomes between arms, using intent-to-treat approach. Race was examined as an effect modifier in the resident outcome model. RESULTS: Most facilities were for-profit (95; 71.4%), and 1973 (26.3%) of residents were Black. Among residents, 82.5% (95% CI, 81.2%-83.7%) were vaccinated in the intervention arm, compared with 79.8% (95% CI, 78.5%-81.0%) in the usual care arm (marginal difference 0.8%; 95% CI, -1.9% to 3.7%). Among staff, 49.5% (95% CI, 48.4%-50.6%) were vaccinated in the intervention arm, compared with 47.9% (95% CI, 46.9%-48.9%) in usual care arm (marginal difference: -0.4%; 95% CI, -4.2% to 3.1%). There was no association of race with the outcome among residents. CONCLUSIONS AND RELEVANCE: A multicomponent vaccine campaign did not have a significant effect on vaccination rates among SNF residents or staff. Among residents, vaccination rates were high. However, half the staff remained unvaccinated despite these efforts. Vaccination campaigns to target SNF staff will likely need to use additional approaches. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04732819.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Intern Med

DOI

EISSN

2168-6114

Publication Date

March 1, 2022

Volume

182

Issue

3

Start / End Page

324 / 331

Location

United States

Related Subject Headings

  • United States
  • Skilled Nursing Facilities
  • SARS-CoV-2
  • Pandemics
  • Middle Aged
  • Male
  • Humans
  • Health Promotion
  • Female
  • COVID-19 Vaccines
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Berry, S. D., Goldfeld, K. S., McConeghy, K., Gifford, D., Davidson, H. E., Han, L., … Mor, V. (2022). Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities. JAMA Intern Med, 182(3), 324–331. https://doi.org/10.1001/jamainternmed.2021.8067
Berry, Sarah D., Keith S. Goldfeld, Kevin McConeghy, David Gifford, H Edward Davidson, Lisa Han, Maggie Syme, et al. “Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities.JAMA Intern Med 182, no. 3 (March 1, 2022): 324–31. https://doi.org/10.1001/jamainternmed.2021.8067.
Berry SD, Goldfeld KS, McConeghy K, Gifford D, Davidson HE, Han L, et al. Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities. JAMA Intern Med. 2022 Mar 1;182(3):324–31.
Berry, Sarah D., et al. “Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities.JAMA Intern Med, vol. 182, no. 3, Mar. 2022, pp. 324–31. Pubmed, doi:10.1001/jamainternmed.2021.8067.
Berry SD, Goldfeld KS, McConeghy K, Gifford D, Davidson HE, Han L, Syme M, Gandhi A, Mitchell SL, Harrison J, Recker A, Johnson KS, Gravenstein S, Mor V. Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities. JAMA Intern Med. 2022 Mar 1;182(3):324–331.

Published In

JAMA Intern Med

DOI

EISSN

2168-6114

Publication Date

March 1, 2022

Volume

182

Issue

3

Start / End Page

324 / 331

Location

United States

Related Subject Headings

  • United States
  • Skilled Nursing Facilities
  • SARS-CoV-2
  • Pandemics
  • Middle Aged
  • Male
  • Humans
  • Health Promotion
  • Female
  • COVID-19 Vaccines